Treatment
toxicity
EVENTS, ADVERSE EVENT
Cycles 1–4 of treatment included gemcitabine 1,000 mg mAdverse events were graded according to the NCI CTCAE version 4.03. Adverse events were managed according to algorithms based on the specific toxicity as defined in the protocol.